Skip to main content

GIICX

ETF
GIICX · UNKNOWN · 686 holdings

Quick Summary

Price History

Concentration Risk

12.20% Broadly spread
Low risk High risk

The top 10 holdings only account for 12.20%. No single stock can meaningfully hurt this fund — you'd need a broad market selloff to see real damage.

Sector Allocation

Consumer Cyclical
0.32%
Healthcare
0.10%
Financial Services
0.05%

Top 10 Holdings

12.20% of fund
SAP SE SAP SE
1.59%
ASML Holding NV ASML Holding NV
1.46%
Roche Holding AG Roche Holding AG
1.23%
Nestle SA Nestle SA
1.22%
AstraZeneca plc AstraZeneca plc
1.21%
Novartis AG Novartis AG
1.15%
Shell plc Shell plc
1.15%
HSBC Holdings plc HSBC Holdings plc
1.15%
Siemens AG Siemens AG
1.04%
Commonwealth Bank of Commonwealth Bank of Australia
1.01%
Other positions
1.89%

All Holdings (686)

Top 10: 12.20% of fund
# Ticker Name Weight Shares Market Value
1 SAP SE SAP SE 1.59% 43,746 12.52 M
2 ASML Holding NV ASML Holding NV 1.46% 16,499 11.45 M
3 Roche Holding AG Roche Holding AG 1.23% 30,732 9.67 M
4 Nestle SA Nestle SA 1.22% 109,760 9.57 M
5 AstraZeneca plc AstraZeneca plc 1.21% 64,960 9.47 M
6 Novartis AG Novartis AG 1.15% 79,646 9.02 M
7 Shell plc Shell plc 1.15% 250,772 9.00 M
8 HSBC Holdings plc HSBC Holdings plc 1.15% 740,381 9.00 M
9 Siemens AG Siemens AG 1.04% 31,839 8.16 M
10 Commonwealth Bank of Commonwealth Bank of Australia 1.01% 70,107 7.96 M
Showing top 10 of 686 holdings · Listed: 98.11% · 1.89% in other positions

السعر المستهدف للمحللين

لا تتوفر تغطية محللين

Growth

Rev 5Y: N/A · Earnings 1Y: N/A
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A

Profitability

ROE: N/A · Net Margin: N/A
Revenue (TTM) N/A Net Income (TTM) N/A
ROE N/A ROA N/A
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) N/A
ROIC N/A FCF Growth (3Y) N/A

Safety

D/E: N/A · Current: N/A
Debt / Equity N/A Current Ratio N/A
Interest Coverage N/A Asset Turnover N/A
Working Capital N/A Tangible Book Value N/A

Dividends

Yield: N/A · Payout: N/A
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A

Valuation

P/E: N/A · EV/EBITDA: N/A
P/E Ratio N/A Forward P/E N/A
P/B Ratio N/A P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield N/A
Market Cap N/A Enterprise Value N/A

Per Share

EPS: N/A · FCF/Share: N/A
EPS (Diluted TTM) N/A Revenue / Share N/A
FCF / Share N/A OCF / Share N/A
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A

Efficiency

FCF Conv: N/A · CapEx/Rev: N/A
CapEx / Revenue N/A FCF Conversion N/A
SBC-Adj. FCF N/A Growth Momentum N/A

مقارنة الأقران

مقابل وسيط قطاع ETF (25157 نظير)
المقياس السهم وسيط القطاع
P/E
P/B
ROE %
Net Margin %
Rev Growth 5Y %
D/E